Sponsor Program Name/ URL Synopsis Current Deadline Date(s)DFID Frontier Technologies Hub £500,000 DFID Grant Funding The DFID Frontier Technologies Hub COVID Action Data Challenge invites you to submit data

innovations that can support LMICs with up to £50,000 per solution in the following categories:

- Data-use solutions that support data integration and analysis

- Data sources and collection tools that inform response

- Epidemiological modelling to support response and planning

- Responsible data needs in COVID-19 data systems

Selected applicants can receive a mix of support, including grant funding for rapid deployment and

matchmaking with DFID and other donors for additional resources at a virtual showcase on or

around 20 May, 2020.

For more info, check: https://medium.com/frontier-technology-livestreaming/apply-now-data-

challenge-for-covidaction-9de45cbe37f

9-May-20

COVID-19 Funding Opportunities

Emergency Medicine

Foundation, US

COVID-19 Research Grant The goals of the Emergency Medicine Foundation COVID-19 Grant are to conduct research that will

provide high-impact new knowledge to advance emergency patient care, improve response of

hospitals/healthcare and EMS systems, and protect emergency medicine healthcare professionals

during pandemics.

Topics may include, but are not limited to, the following:

• Personal Protective Equipment (PPE), including Design, Cleaning, Re-use • Ventilator Scarcity •

Telemedicine • Laboratory Testing • Rapid Screening, Triage and Testing • Clinical Diagnosis •

Epidemiology of Disease • Therapeutics • Diagnostic Radiology, including Point of Care Ultrasound

• Emergency Medicine Workforce, including Safety • Emergency Physician Wellness • Special

Populations, such as High Risk, Homeless, Non-English Speaking, Transplantation Patients

ELIGIBILITY: An emergency physician must be a Principal or Co-Principal Investigator. Co-

Investigators from the emergency medicine team or other disciplines are encouraged. The Principal

Investigator will make all arrangements for conduct of the proposed research and assumes

responsibility for conducting the research projects and supervising the work of all associate

investigators.

Research must be approved by the institutional review board (IRB)or its equivalent, and a copy of

the approval or pending approval sent with this application. IRB approval must be documented prior

to dispensation of EMF funds.

The Principal Investigator must demonstrate that their research project will be active and in place

by July 1, 2020. Grant requests can range from $10,000 to $50,000.

June 5, 2020 at 6:00 pm EST

European Open Science Cloud Fast track Process for Covid-19 Co-

creation Request

EOSC is an ideal tool to respond to public emergencies such as the COVID-19 virus by:

- opening up scientific data on the virus,

- sharing live on-the-ground data on the spread of the virus, as well as software, standards and

processes for monitoring COVID-19 treatment and development,

- accessing and combining this data not only to eradicate the virus but learn how to deal with similar

viruses and future outbreaks,

- assessing the validity of epidemic information in relation to the virus by ensuring that its sources

can be traced and verified.

The EOSC Secretariat will fund initiatives related to EOSC for an amount of 45.000 EUR max.

Individuals or natural persons and legal entities residing in the Member States of the European

Union (EU), including their outermost regions and the associated countries (AC) can apply.

Applications will be evaluated on a

weekly basis.

Innovations for Poverty Action,

US

Peace & Recovery Program:

COVID-19 Off-Cycle Funding

IPA's Peace & Recovery Program is pleased to announce that it is now accepting off-cycle proposals,

capped at $50,000, for time-sensitive research projects and additions to research projects that

study or support the COVID-19 response. 

We have two priorities for our COVID-19 off-cycle funding. To the degree possible, successful

proposals will address both. 

To produce information that can directly inform the humanitarian response to COVID-19 

To produce generalizable knowledge that contributes academic literature on resilience, response,

and recovery.

Researchers worldwide may apply, though the focus of the project must be LMICs. Researchers

must be affiliated with an academic institution, and either hold a PhD or be currently pursuing a PhD

in a relevant discipline. Practitioners and institutions that implement interventions should partner

with academics. Interdisciplinary teams are encouraged. Funding cannot be spent in high-income

countries and strong priority is given to the UK Department for International Development priority

countries.

For more info on application instructions: https://www.poverty-action.org/publication/peace-

recovery-program-application-instructions

No Deadline

Islamic Development Bank

(IsDB)

IsDB Transform Fund Call for

Innovation 2020

The Transform Fund Call for Innovation 2020 focuses on supporting Member Countries coronavirus

response and long-term pandemic preparedness.

This Call for Innovation will identify, encourage and reward innovative COVID-19 Digital Response

proposals that will benefit local communities focused on the application of advanced technology for

improved diseases surveillance systems and patient care, including: Artificial Intelligence, Big Data,

Blockchain, and Internet of Things.

IsDB investments in innovative ideas will be translated into real development solutions that will

address development challenges and empower the communities and youth in particular to realize

their full potential.

Grant funding and equity investment levels are:

New Ideas with Proof of Concept: US$50,000-100,000 Grants

Capacity Building in Technology and Innovation: US$100,000-150,000 Grants

Scaling Up of Innovative Projects: US$300,000 Equity Participation

Technology Commercialization: US$1,000,000 Equity Participation

The IsDB-STI Fund will support eligible scientists, innovators, SMEs and institutions that need initial

June 1, 2020

Medical Research Council (MRC) COVID-19 Rapid Response Rolling

Call

MRC is now launching rolling call for rapid research proposals with potential to deliver public health

impacts within 12 months. Short term (up to 12 month) proposals are sought. All proposals will

need to be able to show how progress within the period of award could make a significant

contribution to the understanding, prevention and/or management of the COVID-19 outbreak. As

this is a rolling call there is currently no fixed end date to the call, MRC is open to applications and

will aim to review complete proposals within 4 weeks of submission. PI must be hosted by a UK

institution, however, researchers from overseas research organisations in affected countries

providing important local engagement and context are welcomed as Co-Investigators on proposals.

The size of grants will vary according to the needs of each research project but will need to provide

a robust case for value for money.

No Deadline

Mercatus Center at George

Mason University

Fast Funding for COVID-19

Science

A new funding opportunity titled “Fast Funding for COVID-19 Science” was issued by the Mercatus

Center at George Mason University.

Fast Grants are for projects on COVID-19-related science between $10k to $500k for a period of 6

months and decisions are made in under 48 hours. Applicant must be already working on a project

that could help with the COVID-19 pandemic within the next six months, and in need of additional

funding to complete the project. This grant will pay at most 10% in overhead costs to the university.

Fast Grants opened on Tuesday, April 7, 2020. The first grant will be awarded on April 12.

Subsequent decisions will be made within 48 hours.

No Deadline

Mozilla Foundation, US COVID-19 solutions fund Mozilla is announcing today the creation of a COVID-19 Solutions Fund as part of the Mozilla Open

Source Support Program (MOSS). Through this fund, they will provide awards of up to $50,000 each

to open source technology projects which are responding to the COVID-19 pandemic in some way.

As part of the COVID-19 Solutions Fund, they will accept applications that are hardware (e.g., an

open source ventilator), software (e.g., a platform that connects hospitals with people who have 3D

printers who can print parts for that open source ventilator), as well as software that solves for

secondary effects of COVID-19 (e.g., a browser plugin that combats COVID related misinformation).

Applications from anywhere in the world to the extent legally permitted will be accepted and

reviewed on a rolling basis.

The MOSS committee will only consider projects which are released publicly under a license that is

either a free software license according to the FSF or an open source license according to the OSI.

Projects which are not licensed for use under an open source license are not eligible for MOSS

funding.

To apply, please visit: https://mozilla.fluxx.io/apply/MOSS

No Deadline

National Bureau of Economic

Research

Research grants on women,

victimisation and COVID-19

The National Bureau of Economic Research (NBER), with the generous support of the Bill and

Melinda Gates Foundation, seeks to advance understanding of women’s role in the economy by

supporting early-stage research projects. The NBER is offering approximately four research grants of

$20,000 each to support projects related to women, victimization, and domestic violence, with

particular emphasis on the impact of the current COVID-19 pandemic. Research projects that focus

on both developing and developed nations are welcome. Grant funds may be used to cover costs

associated with travel, data acquisition, and other research expenses. They may not be used to

cover salary for project investigators. The grant term in each case will be from June 1, 2020 to June

30, 2021.

Applications, consisting of a research proposal of no more than three pages, an itemized budget,

and a brief (three-page maximum) curriculum vitae for the principal investigator(s), should be

compiled into a single PDF file and uploaded to:

https://papers.nber.org/confsubmit/backend/cfprop?id=WEs20

Applicants must be current affiliates of an academic institution. Applications from doctoral and post-

doctoral students should include a one-page letter of recommendation from a senior researcher,

such as a dissertation advisor, who is knowledgeable about the project. When a substantial part of

the grant request will be used for data collection or production, grant recipients are encouraged to

make the resulting data publicly available to the extent possible, for example within the limits of

confidentiality agreements, and to discuss this possibility in the proposal.

Applications are especially welcome from untenured faculty members, and post-doctoral and

advanced doctoral students, from researchers with and without NBER affiliations, and from

researchers who are members of groups that are under-represented in economics.

11:59pm EDT on Monday May 11,

2020

National Institute of Allergy and

Infectious Diseases (NIAID)

Notice of Special Interest (NOSI)

regarding the Availability of

Emergency Competitive Revisions

for Research on Severe Acute

Respiratory Syndrome

Coronavirus 2 (SARS-CoV-2) and

Coronavirus Disease 2019 (COVID-

19)

NIAID is issuing this Notice of Special Interest (NOSI) to highlight the need for research on Severe

Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).

NIAID is particularly interested in projects focusing on viral natural history, pathogenicity,

transmission, as well as projects developing medical countermeasures and suitable animal models

for pre-clinical testing of vaccines and therapeutics against SARS-CoV-2/COVID-19.

Applications in response to this NOSI must be submitted using the following targeted funding

opportunity:

PA-20-135; Emergency Competitive Revision to Existing NIH Awards (Emergency Supplement -

Clinical Trial Optional), which is intended to provide funds for NIH grantees applying to expand the

scope of their active grant.

The award project period of the Competitive Revision must not exceed two years.

Application budgets should not exceed the annual amount of the current parent award and should

reflect the actual needs of the proposed project. Exceptions will be considered on a case-by-case

basis.

Applications will be accepted on a

rolling basis 03/25/2020 from

03/25/2021 through 5:00 PM local

time of the applicant organization.

National Institutes of Health

(NIH)

Secondary Analysis of Existing

Datasets for Advancing Infectious

Disease Research (R21 Clinical

Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to support projects that utilize

open-access data, alone or in combination with other datasets, to address knowledge gaps in basic

and/or clinical research in infectious diseases.

This primary objective of this FOA is to invite applications that seek to answer novel scientific

questions by using data in the BRCs. Research projects may propose combining data from other

data repositories, including private user-generated data but must use data in the BRC. Projects

focused on influenza, Mycobacterium tuberculosis (TB), antimicrobial resistance and malaria are

encouraged although projects based on other pathogens relevant to NIAID will be supported. Data,

tools and other resources generated are expected to meet the FAIR principles and credit all

contributors including data generators. Applicants are encouraged to contact the

Scientific/Research staff listed below to ensure proposed projects are within the scope of this

funding opportunity.

Direct costs are limited to $275,000 over a two-year project period, with no more than $200,000 in

direct costs allowed in any single year.

Standard dates apply: February 16,

June 16, October 16

Pfizer, INT COVID-19 competitive grant

programme

Pfizer invites applications for its COVID-19 competitive grant programme. The following grants are

available:

•independent medical education grants – to support educational programmes for healthcare

providers focused on the recognition, diagnosis, treatment and overall care management of

patients with COVID-19;

•quality and process improvement grants – to support hospitals or healthcare systems so that they

may evaluate and improve their systems of care for COVID-19 patients.

Expected approximate range of grant awards: $20,000 to $250,000 USD (Pfizer maintains a

company-wide, maximum allowed overhead rate of 28% for independent studies and projects).

Applications should be submitted at www.cybergrants.com/pfizer/knowledge.

22-May-20

Therapeutic Innovation

Australia, AU

Pipeline accelerator COVID-19

rapid response

During the current COVID-19 pandemic, TIA's network of core facilities and screening facilities

continue to be accessible by all researchers.  These facilities enable therapeutic development

projects in support of national and international efforts to combat COVID-19.

In response to COVID-19 pandemic, TIA is launching a voucher-style researcher access scheme,

called Pipeline Accelerator COVID-19. This round of scheme is designed to respond quickly to the

needs of researchers and industry engaged in research related to COVID-19.

 

Applications are open to university-based researchers and research groups, research groups within

public funded research organisations, including medical research institutes, university or medical

research institute’s technology transfer office, or organisations and commercial entities that meet

the general eligibility criteria for the R&D tax incentive. Applications from international

organisations will also be considered. The project must require access to a TIA -supported facilities

and applications must be made with this centre’s involvement and agreement. Multiple providers

can be named on an application if the project makes use of capabilities at several different facilities.

Two levels of funding are offered; multiple grants of AUD 5,000 each, up to a total value of AUD

20,000 or a single grant of AUD 50,000 provided directly to the service provider. Applications are

expected to demonstrate a cash co-investment of at least 25 per cent of the requested award.

First round of applications closes

15th May 2020. 

Second round of applications closes

5th June 2020. 

World Health Organization

(WHO)

Call for proposals for Research in

Priority Areas of Public Health

“EMRPPH” 2020-2021

World Health Organization and Regional Office for the Eastern Mediterranean (WHO/EMRO) issued

a call for proposals titled “Eastern Mediterranean Regional Office - Special Grant for Research in

Priority Areas of Public Health” (EMRPPH) for 2020-2021, including COVID-19 research (see

attached document).

The focus for this round is the strategic directions identified by the Regional Director, WHO/EMRO

in “EMR Vision 2023”, including: expanding universal health coverage, addressing health

emergencies, and promoting healthier populations, with special emphasis on cross-cutting

initiatives as: environmental health and food safety; as well as: science, information, and

dissemination. This round of calls, includes a special call for COVID-19 research in response to the

related pandemic and the importance of the issue for all countries of the region. Related

submissions are given utmost priority in review and recommendation for funding, as appropriate.

The EMRPPH award amount will range from $ 10,000 - 15,000 for each proposal, and the proposed

duration for which support is requested must not exceed 10 months (expect for COVID-19 related

research which could range from $ 10,000 – 30,000, as relevant to the topic and justified in the

proposal). Individuals and institutions engaged in EMR health research are considered eligible for

submitting proposals which include academic institutions in EMR countries.

1 June, 2020

Social Science Research Council,

US

Rapid-response grants on COVID-

19 and the social sciences

In partnership with the Henry Luce Foundation, The Social Science Research Council (SSRC), as part

of its Covid-19 Initiative, seeks proposals from across the social sciences and related fields that

address the social, economic, cultural, psychological, and political impact of Covid-19 in the United

States and globally, as well as responses to the pandemic’s wide-ranging effects.

The Covid-19 Rapid-Response Grants invites proposals from researchers who hold a PhD in any

social science disciplines or related interdisciplinary fields. The grants offer research support for up

to six months toward research-related expenses. These include, but are not limited to, access to

data sets, archives and relevant publications, costs related to conducting online research of various

kinds, and research assistance. Applications are welcome from any country around the world.

Awards will range from USD$2,000 to $5,000, with the possibility of slightly more support for

collaborative projects of two or more researchers.

Applications must be submitted through the SSRC’s online application system by 11:59 p.m. EST,

June 1, 2020. Applications will consist of a five-page research proposal, an application form, budget,

and a curriculum vitae. Awards will be announced in July 2020.

1-Jun-20

Royal Academy of Engineering,

GB

Pandemic preparedness The Engineering X Pandemic Preparedness programme is supporting the UK and global engineering

community to learn from the current COVID-19 pandemic through global sharing of lessons on

disruptive solutions and best practice approaches in the prevention, preparedness, response and

recovery from pandemics.

This scheme provides up to £20,000 for projects of a duration up to 12 months. Teams making

proposals should include at least one engineer. Projects should use an interdisciplinary,

collaborative approach to tackle pandemic-related challenges in any field, with impact at global,

regional or local levels.

The deadline for this scheme is 1pm (UK time) on 1 June 2020. Applicants can expect a decision on

or before 22 June, so that projects can start on 1 July.

There are two eligibility streams for this programme:

Stream 1 is funded under the Global Challenges Research Fund (GCRF) and must be aimed to tackle

challenges faced in countries on the DAC list

Stream 2 will fund innovation projects in UK Universities

In the first instance this call is only open to lead applicants with whom the Academy itself - or a

National Academy of Engineering from another country - has an existing or previous relationship.

For example, as a named grant holder, collaborator, a partner on a current or previous grant, or an

Academy Fellow or Member.

A second grant call for proposals is expected to launch in July 2020.

1-Jun-20

NIHR Global Effort on COVID-19 (GECO)

Health Research' Funding

Programme

The focus of this call is on understanding the pandemic and mitigating its health impacts in low and

middle-income countries (LMIC). The call prioritises epidemiology, clinical management, infection

control and health system responses. Applications are particularly encouraged from LMIC Principal

Investigators (PIs), as well as PIs based in the UK working in equitable partnerships with LMIC

investigators. Applicants must have a relevant academic affiliation to an eligible institution in an

LMIC or the UK.

The call specification is based on the World Health Organization (WHO) COVID-19 Global Research

Roadmap priorities identified through a consultative process. Areas 3, 4, 5 and 9 from the WHO

Roadmap are in scope:

Thematic Area 3: Epidemiological studies

Thematic Area 4: Clinical management

Thematic Area 5: Infection prevention and control including health care workers' protection

Thematic Area 9: Social sciences and humanities in the outbreak response.

Proposals can request up to £1 million. Funding can last for up to 18 months and applicants should

be ready to start the research within four weeks of being notified of an award.

22 June 2020 (12:00 BST)

10 August 2020 (12:00 BST)

28 September 2020 (12:00 BST)

UK Research and Innovation

(UKRI)

UKRI GCRF/Newton Fund Agile

Response Call to Address COVID-

19

Proposals are invited for short-term projects addressing and mitigating the health, social, economic,

cultural and environmental impacts of the COVID-19 outbreak in Low and Middle Income Countries

UKRI will support excellent proposals which meet at least one of the following:

- New research or innovation with a clear pathway to impact on policy or practice that has the

potential (within the period of the award) to deliver a significant contribution to the understanding

of, response to, and recovery from the COVID-19 pandemic in a developing country context.

- Supports the manufacture and/or wide scale adoption of an intervention with significant potential

for impact in developing countries.

- Gathers critical data and resources quickly for future research use.

Proposals will be accepted by anyone based in a UK Research Organisation (RO) eligible to receive

funding from UKRI Research Councils or based in approved Research Organisations overseas. It is

expected that proposals will engage equitably with research organisations, other organisations, and

communities in the partner countries or LMIC countries where impact will be delivered. Proposals

must have a minimum of one Co-Investigator based in a country identified on the OECD DAC list of

ODA recipients and where possible we would expect involvement of Co-Investigators based in the

country/ countries in which the study is situated.

LMIC country Principal Investigators from an organisation that lead or have previously led and held

UKRI grants and have undergone Je-S registration and due diligence checks are eligible to be lead

applicants for this call.

There is no specific budget for this call. Research of any scale that can demonstrate it will deliver

impact during the lifetime of the project is invited. Costs for Principal and Co-Investigators from

LMICs will be covered at 100% fEC

31 December 2020, but applicants

may apply at any time.

FOREUM Foundation FOREUM Special Call for Research

Proposals on COVID-19 in RMDs

FOREUM seeks to support projects in the following areas:

- Investigations that provide insights into the clinical course of COVID-19 in patients with RMD

compared to non-RMD patients (international registers, cohorts, clinical studies)

- Projects that address diagnostic and therapeutic challenges of SARS-CoV-2 infection in RMD

patients

- Research on pathogenic mechanisms (e.g. cytokine release syndrome) in the context of COVID-19

The call shall be open to participants from EULAR membership countries. Also, the Principal

Investigator should come from a EULAR membership country. Centers from non- EULAR

membership countries can participate as partners in exceptional cases (e.g. specific scientific

expertise), but will not be eligible to receive research funding. The participation of patient research

partners is strongly recommended for clinical research projects and should be considered for all

other research projects.

Available funding is as follows:

Individual (monocentric) proposal: up to €100,000

Collaborative proposal: up to €300,000

The maximum duration of a project is three years. Projects with a duration beyond one year will be

subject to periodic progress evaluations.

7 June 2020.

spencer Foundation Research

Grants on Education

COVID-19 Related Special Grant

Cycle

The Foundation's Research Grants on Education: COVID-19 Related Special Grant Cycle supports

academic research projects that will contribute to understanding the rapid shifts in education and

methods for improving education during the coronavirus pandemic. The call is 'field-initiated' in that

proposal submissions are not required to focus on a particular research topic, discipline, design or

method. It is hoped that researchers will identify the most compelling and needed areas of

immediate research.

There are two primary categories of project that the Foundation is interested in funding:

- Studies that aim to understand and disrupt the reproduction and deepening of educational

inequality caused by the COVID-19 crisis.

- Research projects that are working to reimagine educational opportunities.

Proposals can be at all levels and in all settings of learning, including early childhood, higher

education, and in schools, families and communities. Projects will be supported that are

multidisciplinary, span a wide range of topics and use various methodological perspectives, thus

utilising a wide range of research methods.

Principal Investigators (PIs) and Co-PIs applying must have an earned doctorate in an academic

discipline or professional field, or appropriate experience in an education research-related

profession. PIs must be affiliated with a non-profit organisation that is willing to serve as the

administering organisation if the grant is awarded, such as a college, university, school district,

research facility or other non-profit organisation. Proposals are accepted from the US and

internationally.

Grants are limited to $50,000 for projects ranging from one to three years.

8 June 2020

Microsoft Corporation, US Artificial intelligence for health –

COVID-19 grant

The Microsoft Corporation invites proposals for its artificial intelligence for health COVID-19 grant.

This supports research with potential benefits and a defined impact to the COVID-19 response.

Research should focus on one of the following areas:

•data and insights to inform on people’s safety and economic impacts;

•treatment and diagnostics, enabling research to further the development of vaccines, diagnostics

and therapeutics;

•allocation of resources, including recommendations on the allocation of limited assets, such as

hospital space and medical supplies;

•dissemination of accurate information to minimise misinformation sharing;

•scientific research to study and understand COVID-19.

Applicants may be nonprofits, academia or governments.

The grant provides Azure cloud and high-performance computing capabilities.

15-Jun-20

Medical Research Council, GB

and other funders

Health Systems Research

Initiative Call 7: Providing

evidence to strengthen health

systems in low and middle

income countries

In recognition of the current COVID-19 pandemic, the funders welcome proposals to research:

- the impact of the pandemic on health systems (this does not need to focus directly on COVID-19, it

could explore wider health systems research beyond containing the infection, for example knock on

effects on health systems provision)

- and examine ways to enable health systems to respond to this or future pandemics more

effectively.

The funders do not expect everyone to do COVID-19 related research. For those not doing COVID-19

related research, funders do require an honest assessment of how the pandemic might affect the

research plans.

Please note, COVID-19 related proposals will be assessed according to the scheme specific

assessment criteria in a competitive manner with wider non-COVID-19 research proposals. No

specific budget is allocated.

Foundation grants support smaller and shorter projects. Proposals may be exploratory or for

projects to conduct pilot work to build necessary knowledge and methodological base to support a

future full proposal.

Researchers based at research organisations in the UK or LMICs may apply. Projects with a LMIC PI

are strongly encouraged and all proposals must include co-investigators from the LMIC in which the

research is to take place.

Grants are worth up to £200,000 each for up to two years.

28-May-20

ELRHA RESEARCH TO SUPPORT COVID-19

RESPONSE IN HUMANITARIAN

SETTINGS

Elrha is launching an urgent funding call for research proposals to support the COVID-19 response in

humanitarian settings.

The call aims to fund public health research that will produce robust findings that will contribute to

the effectiveness of the current humanitarian response and increase the evidence base for future

responses to similar infectious disease outbreaks.

Round 1: 18.00 (GMT+1) on 13 April

2020

Round 2: 18.00 (GMT+1) on 20 April

2020

Round 3: 18.00 (GMT+1) on 4 May

2020Medical Research Council (MRC) COVID-19 Rapid Response Rolling

Call

MRC is now launching rolling call for rapid research proposals with potential to deliver public health impacts

within 12 months. Short term (up to 12 month) proposals are sought. All proposals will need to be able to show

how progress within the period of award could make a significant contribution to the understanding, prevention

and/or management of the COVID-19 outbreak. As this is a rolling call there is currently no fixed end date to the

call, MRC is open to applications and will aim to review complete proposals within 4 weeks of submission. PI

must be hosted by a UK institution, however, researchers from overseas research organisations in affected

countries providing important local engagement and context are welcomed as Co-Investigators on proposals. The

size of grants will vary according to the needs of each research project but will need to provide a robust case for

value for money.

As this is a rolling call there is currently

no fixed end date to the call, MRC is

open to applications and will aim to

review complete proposals within 4

weeks of submission.

Mercatus Center at George Mason

University

Fast Funding for COVID-19

Science

Fast Grants are for projects on COVID-19-related science between $10k to $500k for a period of 6 months and

decisions are made in under 48 hours. Applicant must be already working on a project that could help with the

COVID-19 pandemic within the next six months, and in need of additional funding to complete the project. This

grant will pay at most 10% in overhead costs to the university.

Fast Grants opened on Tuesday, April 7,

2020. The first grant will be awarded on

April 12. Subsequent decisions will be

made within 48 hours.

National Council for Scientific

Research – Lebanon (CNRS-L)

CNRS-L COVID-19 Flash Call The National Council for Scientific Research – Lebanon (CNRS-L) is launching a “Flash Call” on “COVID-19

Management in Lebanon” to provide financial support for effective medical, scientific and technical proposals

that ensure short-term and quick practical outputs to address the current challenges, and enable the health sector

in Lebanon to directly benefit.

The “Flash Call” will run between March 24 and April 22, 2020.

Further details (Call and Application forms) are available on the following link:

https://tinyurl.com/tnyen6u OR http://www.cnrs.edu.lb

22-Apr-20

Sponsor Program Name/ URL Synopsis Current Deadline Date(s)

Agency for International

Development (USAID)

HELIX APS:

Supporting Holistic

and Actionable

Research in

Education (SHARE)

Addendum

Agency for

International

Development

The Supporting Holistic and Actionable Research in Education (SHARE) Addendum is

not a Request for Application (RFA) but rather a request for Concept Note(s) in

response to this Addendum published under the HELIX APS. To be competitive, the

Concept Note submission must be fully responsive to all directions under this

Addendum and HELIX APS. Based on the submitted Concept Note, USAID’s E3 Bureau’s

Office of Education (E3/ED) will determine whether to request a Full Application from

an eligible organization.

Estimated Total Program Funding: $40,000,000

Award Ceiling: $40,000,000

Award Floor: $15,000,000

May 01, 2020  

Other Funding Opportunities

Agency for International

Development (USAID)

MOMENTUM (Moving

Integrated, Quality

Maternal, Newborn,

and Child Health

Services, Voluntary

Family Planning, and

Reproductive Health

Care [MNCH/FP/RH]

to Scale)

Agency for

International

Development

The purpose is to accelerate reductions in maternal, newborn, and child mortality and

morbidity in high-burden, USAID-supported countries by increasing the capacity of

host country institutions and local organizations to introduce, deliver, scale up, and

sustain the use of evidence-based, quality maternal, newborn, and child health

(MNCH) services, voluntary family planning, (FP) and reproductive health (RH) care.

This main APS document outlines the goal, purpose, expected results, and priorities of

MOMENTUM (Moving Integrated, Quality Maternal, Newborn, and Child Health

Services, Voluntary Family Planning, and Reproductive Health Care [MNCH/FP/RH] to

Scale), and may result in multiple awards issued under subsequent APS Rounds. Note:

When referencing MOMENTUM in this document, it is referring to the full portfolio of

possible awards under this overall purpose. This specific document is an umbrella APS

and will not be accepting concept papers or applications. Prospective applicants will be

provided a fair opportunity to develop and submit competitive concept papers to

USAID for potential funding via discrete Rounds under this APS. For the purposes of the

MOMENTUM APS, a “Round” is defined as a specific program description that falls

under the larger MOMENTUM APS goal, purpose, and results but is tailored to a

certain focus. Under each Round, applicants will first submit a short concept paper that

will be reviewed for responsiveness to the overall MOMENTUM purpose, selected

results, and Round’s focus and then scored according to the evaluation criteria

provided in the Round document. If an applicant is successful in the concept paper

stage, applicant representatives may be invited to join a co-creation process. Following

the co-creation process, selected applicants (individual organizations and/or consortia

developed at concept paper stage or during co-creation) will be requested to submit a

Full Application, the content and format of which will be provided in greater detail by

the Agreement Officer. Publishing this APS does not commit USAID to make any

awards. USAID also reserves the right to not conduct a co-creation process and request

Full Applications from successful applicants at concept paper stage. 

Award Ceiling: $500,000,000

Sep 30, 2025  

Agency for International

Development (USAID)

SCALING OF HERMETIC

POST HARVEST

STORAGE

TECHNOLOGIES AMONG

SMALLHOLDER

FARMERS

The specific, primary objective of this Addendum is:

Scaling postharvest hermetic storage by identifying finance mechanisms to accelerate

adoption and use of hermetic postharvest storage technologies among smallholder

farmers.

Related objectives include the following:

● create or sustain demand for hermetic storage bags,

● enable households to effectively use such technologies through improved postharvest cash flow

and longer periods of hermetic grain storage, and,

● leave a market-viable mechanism for farm households to continue to access

hermetic technologies once the donor-funded activity is completed.

USAID anticipates allocating up to $500,000 over the next fiscal year to contribute to one

partnership.

8-May-20

Agency for International

Development (USAID)

American Schools and

Hospitals Abroad

Program Worldwide

ASHA's Fiscal Year 2020 Request for Applications (RFA) is officially posted. Questions

are due April 1, 2020 at 4pm US EST. Phase I submissions are due May 20, 2020 4pm US

EST. Submissions will not be accepted through the grants.gov portal.

May 20, 2020 4pm US EST

Agency for International

Development (USAID)

The USAID/Lebanon

Broad Agency

Announcement for

Initiative to Deliver

Essential Assistance and

Services (IDEAS)

The United States Government, represented by the United States Agency for

International Development (USAID) through the Mission in Lebanon, is issuing this

Broad Agency Announcement (BAA) to seek participants to co-create, co-design, co-

invest, and collaborate on research and development[1] interventions to improve

delivery of essential assistance and services at the municipal level. USAID invites for-

profit and non-profit, public and private organizations to submit Expression(s) of

Interest (EOI).

April 13, 2020 17:00 EST

Agency for International

Development (USAID)

Locally Led

Development

Agency for International

Development

This Annual Program Statement (APS), issued to specifically support locally led

development, offers USAID Operating Units (OUs: Missions, Bureaus, and Independent

Offices) a mechanism to support locally led development approaches while

upholding U.S. foreign policy objectives of promoting national security, advancing

American values, and supporting global prosperity and self-reliance. Awards resulting

from this APS will support the Journey to Self-Reliance by empowering local actors to

take the lead in identifying and addressing development challenges in their own

communities, countries, and regions. Furthermore, this APS seeks to build upon Agency

policy, guidance, and emerging practice in the areas of systems thinking, collaboration,

learning, and contextually-informed and adaptive design and management. It aims to

advance USAID’s capability to work with local partners, to learn from these

engagements, and to share this learning broadly.

Apr 09, 2020  

Agency for International

Development (USAID)

CALL FOR LOCALLY LED

DEVELOPMENT

CONCEPTS ON

COALESCING

ORGANIZATIONS

TOWARDS LOCALLY LED

ACTIONS TO BOOST

DEVELOPMENT

(COLLABDev)

This Addendum seeks to contribute to the Mission’s implementation of the U.S.

Congressionally directed Local Works program, which advances locally led approaches

to development challenges to promote self-reliance. The specific objective is to

facilitate coalition-building and collaborative action among stakeholders from different

technical sectors through a systems approach to making sense of local actors, their

resources, and their interrelationships.

Subject to funding availability, USAID/Philippines intends to provide a maximum of $1.5

million in total USAID funding over a two-and-a-half-year period. USAID anticipates

awarding one to two Cooperative Agreements or Fixed Amount Awards pursuant to this

Addendum. USAID reserves the right to fund any or none of the applications submitted.

Consortia that include organizations with expertise in facilitating partnerships and/or

utilizing systems-and-networks-based tools or methods for understanding and working

with complex systems are welcome to apply.

May 15, 2020  

Agency for International

Development (USAID)

MOMENTUM (Moving

Integrated, Quality

Maternal, Newborn, and

Child Health Services,

Voluntary Family

Planning, and

Reproductive Health

Care [MNCH/FP/RH] to

Scale)

Agency for International

Development

US. and non-U.S. public, private, for-profit, and nonprofit organizations, as well as

institutions of higher education, public international organizations, and non-

governmental organizations, are eligible to submit a concept paper under each

Round(s) of the APS. Further, the organization must be a legally-recognized,

organizational entity under applicable law, legally registered in a country within the

geographic code 937 (“the United States, the recipient country, and developing

countries other than advanced developing countries, but excluding any country that is a

prohibited source,” per ADS 310.3.1.1). Each recipient must be a responsible entity. The

AO may determine a Pre-Award survey is required and if so, would establish a formal

survey team to conduct an examination that will determine whether the prospective

recipient has the necessary organization, experience, accounting and operational

controls, and technical skills – or ability to obtain them – in order to achieve the

objectives of the program. Organizations in developing countries are strongly

encouraged to apply, inasmuch as they will support not only the objectives of this APS

and the Round(s) they are applying to, but also USAID's objectives to build the

capacities in local organizations that are needed for sustainable development. USAID

strongly encourages applications from potential new partners who meet the eligibility

requirements and are willing to be subjected to a Pre-Award Survey.Concept papers

from organizations that do not meet the above eligibility criteria will not be reviewed

and evaluated. Individuals are not eligible to apply for any Rounds of this APS. Please

see Round-specific additional eligibility criteria for any changes to this information.

30-Sep-25

Agency for International

Development (USAID)

DEVELOPMENT IMPACT

SCIENCE CORPS (DISC)

Agency for International

Development

USAID

This Funding Opportunity (referred to as the DEVELOPMENT IMPACT SCIENCE CORPS

(DISC) program ) is an Addendum under the Science, Technology, Innovation and

Partnership Annual Program Statement (STIP APS).

PLEASE NOTE that all interested organizations should carefully review both this

Addendum AND the broader STIP APS announcement, which can be found at the

following link: https://www.grants.gov/web/grants/view-

opportunity.html?oppId=324217.

Potential Applicants are advised that important information contained in the STIP APS

Apr 06, 2020  

Agency for International

Development (USAID)

YouthPower 2: Youth

Excel AddendumAs described in YouthPower 2 Annual Program Statement (YP2 APS), USAID has a long-

standing history of prioritizing youth needs and investing in youth development through

support to initiatives in multiple sectors, including, but not limited to, reproductive

health and voluntary family planning, education, agriculture, environment, economic

growth, and democracy, human rights and governance. While USAID has demonstrated

a commitment to better integrating youth voices into USAID programs and activities,

there is still a need for increased effort to incorporate youth as valuable partners in

development activities. Previous USAID youth programming has supported small scale

youth-led learning and implementation grants in low- and middle-income countries

(LMICs) that have provided on-the-ground insights into PYD programming. However,

the local youth-led and youth-serving organizations involved in the research had limited

capacity, specifically, knowledge and skill gaps in how to conduct research, analyze

data, and disseminate findings to feed them back into future programming demand

investment in capacity development. 

Apr 30, 2020  

Allen Foundation, Inc. Research grants in

nutritionThe Allen Foundation invites proposals for its research grants. These support projects

that benefit nutritional programmes in the areas of education, training and research.

Proposals that develop and advance the following aims are welcomed:

•the inclusion of mandatory courses in nutrition in medical schools;

•realising the promise of nutrigenomics or nutritional genomics;

•the promotion of environmentally sound, economically viable, socially responsive and

sustainable food and agricultural systems

15-Jan-21

Association for Research

in Vision and

Ophthalmology, US

Genentech age-

related macular

degeneration

research fellowships

The Genentech Age-related Macular Degeneration (AMD) Research Fellowships offers

two grants:

basic research in the understanding of AMD and

translational AMD research focusing on therapeutics (not yet in clinical trials)

Each research fellowship (basic and translational) is $40,000

Applications open on July 1,

2020

Applications close on Sept. 1,

2020

Batten Disease Support and

Research Association

(BDSRA)

BDSRA Annual Funding

Cycle

The Batten Disease Support and Research Association (BDSRA) has issued a request for letters of

intent (RLOI) for the 2020 research grant cycle. BDSRA supports scientific investigations through

an annual merit review process, awarding grants to researchers throughout the world.

For the current call for LOIs, BDSRA seeks innovative research projects that have the potential to

advance therapeutic strategies for all or any of the Neuronal Ceroid Lipofuscinoses. Each award,

depending on funding availability, will be no more than $40,000 for a one-year period.

March ,27, 2020

Bausch + Lomb, US Independent

Research Grant

Independent Research Grants empower the global research community to develop new

treatments and technological advancements in ocular health. Research Grants have

been funded by Bausch + Lomb to improve consumers’ standard of care, efficacy,

patient satisfaction, safety and vision performance

No Deadline

Berytech Innovation factory

acceleration program:

From Research to

market

Berytech is organizing the third Innovation factory acceleration program: From Research to

market allowing researchers and novel startups to develop their innovation into commercially

viable products and applications.

6-Apr-20

Crohn’s and Colitis

Foundation of America

Litwin IBD Pioneers The program encourages novel research into the diagnosis, identification of clinically relevant

subsets, treatments, and cures for inflammatory bowel diseases (IBD) and funds innovative pilot

research so that scientists can test their initial ideas and generate preliminary data.

Litwin IBD Pioneers supports researchers who are exploring all possible opportunities for

diagnostic and therapeutic improvements, including novel, out-of-the-box ideas, and funds

innovative and pioneering ideas that have a clinically relevant focus. Additionally, the program is

open to investigators from other disciplines new to the IBD field, as well as countries outside the

United States.

November 5th, 2019 and May

20th, 2020

Department of Defense Wideband Adaptive RF

Protection (WARP)

Department of Defense

DARPA - Microsystems

Technology Office

DARPA seeks innovative proposals to develop wideband, adaptive RF filters and

cancellers that selectively attenuate interference and protect wideband digital radios

from saturation. When exposed to interference/self-interference, the filters and

cancellers will automatically sense and adapt to the electromagnetic environment

through the intelligent control of its adaptive hardware. WARP will ultimately enable

the use of wideband software defined radios in congested and contested environments

Jun ,11, 2020  

Department of Defense

Dept. of the Army --

USAMRAA

DoD Breast Cancer,

Breakthrough Award

Level 3

Advanced translational studies with a high degree of project readiness. Where relevant, proof of

availability of and access to necessary data, human samples, cohort(s) and/or critical reagents

must be provided. If the proposed research would ultimately require U.S. Food and Drug

Administration (FDA) involvement, applications must demonstrate availability of, and access to,

clinical reagents (e.g., therapeutic molecules) and patient population(s). Applications must state a

realistic timeline for near-term clinical investigation. Small-scale clinical trials (e.g., first in human,

Phase I/Ib) may be appropriate.

24-Jun-20

Department of Defense

Dept. of the Army --

USAMRAA

DoD Breast Cancer,

Breakthrough Award

Level 4

Large-scale projects that will transform and revolutionize the clinical management and/or

prevention of breast cancer. Human clinical trials are required. PIs are expected to have

experience in successfully leading large-scale projects and demonstrated ability (through personal

experience or via a commitment from a collaborating clinical investigator) to implement a clinical

project successfully. Where relevant, applications must demonstrate availability of and access to

necessary data, human samples, cohort(s), and/or critical reagents. For proposed research that

will require U.S. Food and Drug Administration (FDA) involvement, project readiness

requirements at the time of application submission include: proof of availability of and access to

clinical reagents (e.g., therapeutics) that meet regulatory compliance guidelines, proof of

availability of and access to appropriate subject population(s), validated projections for patient

recruitment, and submission of an Investigational New Drug (IND) or Investigational Device

Exemption (IDE) application to the FDA, if applicable.

24-Jun-20

Department of Health and

Human Services

Centers for Disease Control -

NCHHSTP

Strategies to Maintain

HIV Viral Suppression

Among State Prison

Inmates Released to the

Community

This NOFO aims to develop effective, sustainable, and replicable program models that support

continuity of HIV care for PWH released from state prisons into the community. Programs will

emphasize linkage to and retention in community HIV care, adherence to HIV treatment, and

suppression of HIV viral load. Programs should also identify PWH and HIV-negative persons at risk

for HIV among sex and drug-injection partners and associates of program participants and link

them to care.

28-Apr-20

Earth Watch Field research grants Earthwatch supports multidisciplinary field-research projects around the world through

funding and by engaging members of the public in research as citizen-scientist

participants. Through our participatory science model, we support research that

responds to global challenges—from climate change to human-wildlife coexistence to

environmental sustainability—in a manner that engages local communities.

To help understand and address global change, Earthwatch supports hypothesis-driven

scientific field research in ocean, freshwater, and terrestrial ecosystems. We are

especially interested in funding research on sustainable agriculture and forestry, urban

ecology, and ecological restoration.

Data collected by principal investigators (PIs) working with citizen-scientist participants

increases scientific knowledge by producing peer-reviewed publications and informing

management plans and policies that conserve and restore ecosystem services and

biodiversity.

9-Jun-20

EB-ResNet members DEBRA

Austria & DEBRA UK

All Priorities Call 2020 Improving understanding of EB biology to create new concepts for diagnosis and treatment.

Developing disease-modifying and curative therapies.

Preventing and curing severe disease consequences: chronic wounds, fibrosis, and cancer.

Improving clinical care and symptom relief through research.

6 April 2020 15:00

hrs GMT.

Ekhaga Foundation |

Ekhagastiftelsen, SE

Agricultural and medical

research grantsWithin AGRICULTURE the foundation supports research relating to improvement and

further development of ecological agriculture (ecologically well suited agricultural

systems where chemical compounds for fertilization and other uses are replaced with

ecological and biological measures of promoting production). Here the goal should be

the production of high quality food that are well suited at improving the public health

and development. Further, research in preparation and storage of food with natural

technology can be supported.

Within MEDICINE the foundation supports research relating to the improvement and

further development of such methods of healing that are natural and suited to

promote the inherent human ability of self-healing. The holistic view of the human

health, where not only medicine but also the effects of food and environment are

observed, is here of great importance. Research in the significance of the environment

and the way of life for the state of health is also supported. Furthermore, the

foundation is open for contributing to the creation of a research center in Sweden for

biological medicine.

Applications for scholarships and strategic efforts to promote a development consistent

with the aim of the foundation can be accepted. The foundation also welcomes

applications for planning-grants, which are used to get a better foundation for a final

application of further studies. This may be in the form of workshops or seminars that

may also be a part of a dialogue between researchers and the scientific advisory council

of the foundation.

In the first place it is the foundations aim to support strategic and innovative projects.

For applications that do not come from Europe we strongly recommend that you have a

reserach cooperation with a swedish institution where the partner is involved in the

research project. Please be sure to describe the details of the cooperation.

20-May-20

European Comission (EC) Marie Skłodowska-Curie

actions

Co-funding of regional, national and international programmes (COFUND): The Co-funding of

regional, national and international programmes (COFUND) supports organisations in Europe

managing fellowship programmes at the regional, national or international level. For the first

time, doctoral training programmes as well as fellowships for experienced researchers are

supported. This will significantly increase the number of attractive, transnational research training

opportunities in Europe. Furthermore, non-academic organisations are now also able to host

COFUND Fellows, and the programmes may receive a contribution from the EU Structural and

Investment Funds.

29/09/2020

European Comission (EC) Marie Skłodowska-Curie

actions

Individual Fellowships (IF): The Individual Fellowships (IF) support the intra-European mobility of

experienced researchers. They also enable mobility from and to Europe, including reintegration

after a period elsewhere in the world. Non-academic organisations can host part or all of the

fellowship, if this is appropriate for the particular field of research. Applicants apply directly to the

Commission with their research proposal, in liaison with their prospective host institution.

9-Sep-20

European Comission (EC) Marie Skłodowska-Curie

actions

Research and Innovation Staff Exchange (RISE): The Research and Innovation Staff Exchange (RISE)

action supports partnerships of European and/or international organisations to implement a joint

research/innovation project through exchanging their staff, including for short-term placements.

If the partnership is only European, the staff mobility must transfer knowledge and enhance

cooperation between academia and other sectors.

28/04/2020

European Commission Horizon 2020 - Excellent

Science - European

Research Infrastructures

(including e-

Infrastructures)

Funding under the European Commission Horizon 2020 programme for research and

innovation to establish and reinforce the research infrastructure (facilities, resources

and services) to ensure that research communities have the optimum environment to

conduct research and deliver innovation.

5/14/2020

Eversight Research Grants Eversight is pleased to invite proposals from academic, clinical and health services

investigators from their partner institutions for funding promising research projects

concerned with vision problems with special emphasis on projects utilizing human

ocular tissue or research related to corneal surgery, corneal disease and eye banking

(including clinical and business practices). Projects relying solely on animal models will

be considered only when their aims are directly related to investigating corneal

diseases, surgery or eye bank practices. Funding is provided as seed money to develop

promising ideas for research, collect initial data, pilot projects and/or carry out

preliminary laboratory work that could facilitate the submission of full-fledged

applications for more extensive support from private or governmental agencies. Eye &

Vision Research Grants are intended for faculty only (assistant professor level or

above).

April 15, 2020 5

p.m. EDT

Food and Drug

Administration (FDA)

Cooperative Agreement

to Support FDA Land

and Water Initiative

(U01) Clinical Trial Not

Allowed

Department of Health

and Human Services

The grantee will work to promote coherent approaches to sustainable land and water

management. Through projects, studies and information-sharing, the grantee will help

increase scientific understanding of the biophysical and socioeconomic relationships

between land and water resources at the landscape scale, and will provide international

policy guidance aimed at achieving greater management coherence among sectors and

across the full global community. The grantee will help to coordinate and review the

latest research on best practices for environmental monitoring and its relationship to

agricultural practices and food safety. Furthermore, the grantee will help disseminate

the appropriate materials and knowledge gained to a world-wide audience.

The grantee will aim to enhance the agricultural productivity and advance the

sustainable use of land and water systems and promote equitable access to these

natural resources in a context of complex agricultural transitions. Additionally, the

grantee will rely on a strong heritage and expertise in the fields of land and water

development and management.

The grantee will work internationally in several dimensions of sustainable development:

    1. Governance and management of food production systems

    2. The provision of essential ecosystem services; food security; human health

    3. Biodiversity conservation

Jun 01, 2020  

Glaucoma Research

Foundation

Shaffer Grants Strategic Research Goals: Protect and restore the optic nerve, accurately detect

glaucoma and monitor its progress, find the genes responsible for glaucoma,

understand the intraocular pressure system and develop better treatments, and to

determine the risk factors for glaucoma damage using systematic outcomes data.

Shaffer Grants are 1-year grants awarded in the amount of $50,000.

July,15, 2020

Health Effects Institute Health effects of air

pollution

The Health Effects Institute invites preliminary applications for its health effects of air pollution

programme. This supports research on novel and important aspects of the health effects of air

pollutants. The current areas of interest are:

•accountability or effectiveness of air quality regulations;

•strengthening causal interpretation of evidence from existing cohorts;

•contributions of wildland and agricultural burning to air quality and health.

Small to medium grants are worth up to USD 500,000 each for two years. Large grants are worth

up to USD 800,000 for up to three years.

21-Apr-20

Immunodeficiency Canada   The Chaim Roifman

Scholar Award for

Senior Investigators

Research objectives should address one or more of the unique needs of patients with primary

immunodeficiency:

-Study the clinical, cellular and molecular characteristics of genetically determined

immunodeficiency diseases

-Discover improved diagnostic tools for PI

-Advance novel therapeutic approaches for PI

-Advance education of patients and medical professionals

(Preference will be given to Canadian based researchers or collaborators of Canadian

researchers)

Currently not accepting

applications for the Chaim Roifman

Scholar Award for Senior

Investigators.

International Council of

Ophthalmology, INT

ICO-Allergan

advanced research

fellowship

The International Council of Ophthalmology, in partnership with Allergan, invites

applications for the ICO-Allergan advanced research fellowship. This enables a young

ophthalmologist to continue basic or clinical research at a chosen university, preferably

in a foreign country to where they live. Applications will be accepted for research work

in the following areas: glaucoma; neuro-ophthalmology; paediatric ophthalmology;

retina;tumours; uveitis; dry eye; cornea.

15 Jan 21 (Forecast)

International Union of

Geodesy and Geophysics

UGG Grants Program

2020-2023

The programme aims to support projects of importance to the international geophysical and

geodetic community, which will explore new scientific ideas and develop future international

initiatives. Key priority areas for support are as follows:

•creation of a new knowledge in geodesy and geophysics;

•dissemination of data and information on geophysics and geodesy;

•geoscience for sustainable development;

•geoscience and policy interface;

•geoscience education and outreach in developing countries.

Proposals may be submitted by at least two IUGG associations or union commissions.

The annual budget for each round is USD 80,000 and grants are worth up to USD 20,000 each.

1 April 2020 for the first call and 1

April 2022 for the second call

Leverhulme Trust Leverhulme Trust

Research Project GrantsFor researchers based at universities, institutions of higher education or registered

charities with university-equivalent research capacity, to undertake an innovative and

original research project

Value

The maximum grant value is £500,000.

Duration

Research Project Grants may be held for up to five years.

21 March, 4pm

Decision: mid July

1 September, 4pm

Decision: early December

1 December, 4pm

Decision: end March

Lloyd’s Register

Foundation, GB

Research grants The Lloyd’s Register Foundation invites applications for its research grants. These

support engineering-related research on enhancing the safety of the engineering

infrastructure on which modern society relies. Project should address the foundation’s

missions, which are to:

•secure, for the benefit of the community, high technical standards of design,

manufacture, construction, maintenance, operation and performance for the purpose

of enhancing the safety of life and property, at sea, on land and in the air;

•advance public education including within the transportation industries and any other

engineering and technological disciplines.

Grants are awarded to research and education organisations, not individuals, and

applicants may be based in any country.

Funding does not support capital works or infrastructure, and equipment is funded only

as a small proportion of research programmes.

Deadlines on: 30 January 2020,

5 March 2020, 1 April 2020, 30

April 2020, 28 May 2020, 24

June 2020, 27 July 2020, 27

August 2020, 28 September

2020, 28 October 2020, 30

November 2020.

Medical Research Council MRC/AHRC/ESRC

Adolescence, Mental

Health and the

Developing Mind: Call

for Research

Programmes

The Medical Research Council, the Arts and Humanities Research Council and the

Economic and Social Research Council invite outline proposals for innovative and

ambitious interdisciplinary programmes of original empirical research in adolescence,

mental health and the developing mind. This £24M call will support a range of

substantive flagship programmes, each of up to 4-year duration and up to £4M.

September ,15, 2020

16:00 GMT+1

Medical Research Council MRC Applied Global

Health Research Board

The Applied Global Health Research Board supports research that will be of direct and primary

benefit to the health of vulnerable populations living in low and middle income countries (LMICs).

Applied research is defined as research seeking practical solutions to health challenges from late

stage intervention development onwards. This includes implementation research, scale-up

activities, health services research, health economics, health policy research, and research with a

predominantly applied focus that does not fit within the remit of other MRC Boards and Panels.

7 ,April,2020 16:00

GMT+1

Medical Research Council MRC/ESRC/BBSRC-

Versus Arthritis

Advanced Pain

Discovery Platform –

Multidisciplinary

Consortia for Data

Generation

This is a pre-call announcement. The call for Research Programme proposals is due to launch April

2020. More details to follow on the MRC website. The call will make £14m available through 4-

year awards to fund high impact, multidisciplinary consortia that, between them will bring

together researchers across the breadth of biomedical, social, and data sciences. It is expected

that the consortia will embrace complementary access to patients, healthy volunteers and

underpinning technology. Areas of focus could include; multi-omic biology, image data

generation, cognitive and psychosocial factor identification, exploiting existing biological samples

and data and new sample/data collections. It is expected that this programme of work will

support 3-5 multidisciplinary consortia.

Summer 2020 (tbc)

Medical Research Council

(MRC)

ERA-HDHL Call for Joint

Transnational Research

Proposals (PREVNUT)

The aim of this call is to support transnational, collaborative research projects that address

important research questions regarding the prevention of undernutrition in European older

citizens through the consumption of appropriate nutritious food. Subject to conditions of

eligibility and peer review being fully met, up to €1.5M will be available to UK researchers for this

call.

7-Apr-20

Medical Research Council

(MRC)

MRC Applied Global

Health Research Board

The new Board will fund global health research that is embedded within local contexts in low- and

middle-income countries (LMICs). Proposals should focus on ideas that will have real world

practical application to improve health.

Proposals are encouraged to be multidisciplinary. The research objectives need to focus on health

impact, but inputs and activities need not be limited to the health sector.

Round 1

Outline application deadline: 7

April 2020

Applicants informed of outcome of

outline review and full applications

invited: July 2020

Full application deadline: 6 October

2020

Round 2

Outline application deadline: 6

October 2020

Applicants informed of outcome of

outline review and full applications

invited: February 2021

Full application deadline: April

2021

National Institute of Health

(NIH)

International research in

infectious diseases (R01

clinical trial not allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications for

support of high-priority, regionally relevant infectious disease research by international

investigators in resource-constrained countries. Applicant organizations must be headquartered

in foreign (non-U.S.) resource-constrained countries (i.e. low-income economies, lower-middle-

income economies, and upper-middle-income economies by World Bank Classification). Eligibility

status of applicant organizations will be determined by this World Bank Classification list at

application submission date.

July 15, 2020; July 15, 2021; July 15

2022

National Institute of

Standards and Technology

(NIST),

United States Department of

Commerce (DoC)

Measurement Science

and Engineering (MSE)

Research Grant

Programs

NIST is soliciting applications for financial assistance for Fiscal Year 2019 (FY19) within the

following NIST grant programs:

(1) the Associate Director for Innovation and Industry Services (ADIIS);

(2) the Associate Director for Laboratory Programs (ADLP);

(3) the Communications Technology Laboratory (CTL);

(4) the Engineering Laboratory (EL);

(5) Fire Research (FR);

(6) the Information Technology Laboratory (ITL);

(7) the International and Academic Affairs Office (IAAO);

(8) the Material Measurement Laboratory (MML);

(9) the NIST Center for Neutron Research (NCNR);

(10) the Physical Measurement Laboratory (PML);

(11) the Special Programs Office (SPO); and

(12) the Standards Coordination Office (SCO).

Applications will be accepted and

considered on a rolling basis as

they are received (2019)

National Institutes of Health

(NIH)

PAR-20-084 NIBIB Trailblazer Award for New and Early Stage Investigators (R21 Clinical Trial Optional)

This Trailblazer Award is an opportunity for NIH-defined New and Early Stage Investigators

(https://grants.nih.gov/policy/early-investigators/index.htm) to pursue research programs of high

interest to the NIBIB that integrate engineering and the physical sciences with the life and/or

biomedical sciences. A Trailblazer project may be exploratory, developmental, proof of concept,

or high risk-high impact, and may be technology design-directed, discovery-driven, or hypothesis-

driven. Importantly, applicants must propose research approaches for which there are minimal or

no preliminary data.

February 16, June 16, October 16

until January 08, 2023

National Institutes of Health

(NIH)

PAR-20-038 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery

and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)

This Funding Opportunity Announcement (FOA) invites research grant applications that propose

the development and evaluation of novel radioligands for positron emission tomography (PET) or

single photon emission computed tomography (SPECT) imaging in human brain and the

incorporation of pilot or clinical feasibility evaluation from previously collected data in pre-clinical

studies. These studies are expected to provide the requisite data needed to advance promising

PET ligands for use in clinical research. Projects proposing only preclinical animal studies should

consider the companion FOA PAR-20-037 .

February 5, June 5, October 5 until

January 08, 2023

National Institutes of Health

(NIH)

PAR-20-037 Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery

and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites research grant applications that propose

the preclinical development of novel radioligands for positron emission tomography (PET) or

single photon emission computed tomography (SPECT) imaging in rodent and nonhuman primate

brain and incorporation of pilot or clinical feasibility evaluation in pre-clinical studies and

appropriate model development.

February 5, June 5, October 5 until

January 08, 2023

National Institutes of Health

(NIH)

R01 Research Project

Grant

This Funding Opportunity Announcement (FOA) will support the development of state-of-the-art

projects that include imaging, biomarkers, digital pathomic and other -omic integration strategies

for improving current approaches for the earliest detection of premetastatic aggressive cancer as

well as identifying precancerous lesions that will subsequently demonstrate an aggressive

phenotype. This FOA specifically attempts to address and improve diagnostic uncertainty in

clinical decisions in a technology agnostic manner by improving sensitivity and specificity of

applied tests. N-dimensional co-registered, cross-correlated imaging results integrated with

multiplexed biomarker data and digital pathomics using analytic strategies such as artificial

intelligence and virtual reality visualization for improving discovery are encouraged. The projects

supported by this FOA will collectively participate in the existing Consortium for Imaging and

Biomarkers (CIB) Research Program. The goals of the CIB are to: (1) improve diagnostic

performance by developing methodology for the early identification of lethal cancer versus non-

lethal disease, (2) to minimize/better manage overdiagnosis and (3) to reduce false positives and

false negatives. Application budgets are not limited but need to reflect the actual needs of the

proposed project.

Letter of Intent Due Date(s)

30 days prior to the application due

date

Application Due Date(s)

July 10, 2019; December 10, 2019;

July 10, 2020; December 10, 2020;

July 9, 2021; December 10, 2021,

by 5:00 PM local time of applicant

organization.

National Institutes of Health

(NIH)

R03 Small Grant

Program

The purpose of this Funding Opportunity Announcement (FOA) is to support innovative

approaches to identifying, understanding, and developing strategies for overcoming barriers to

the adoption, adaptation, integration, scale-up and sustainability of evidence-based interventions,

tools, policies, and guidelines. Conversely, there is a benefit in understanding circumstances that

create a need to stop or reduce (“de-implement”) the use of interventions that are ineffective,

unproven, low-value, or harmful. In addition, studies to advance dissemination and

implementation research methods and measures are encouraged. Application budgets are limited

to $50,000 in direct costs per year up to two years. Examples of the types of projects that the R03

grant mechanism include, but are not limited to, the following:

Pilot or feasibility studies;

Secondary analysis of existing data;

Small, self-contained research projects;

Development of research methodology; and

Development of new research technology.

Letter of Intent Due Date(s)

30 days prior to the application due

date

Application Due Date(s): Every

February 16, June 16, and October

16 until May 8, 2022

National Institutes of Health

(NIH)

R21/R33 Phased

Innovation Award

The purpose of this initiative is to support projects which exploit genome or epigenome editing to

functionally validate and characterize genes or variants involved in substance use disorder-

relevant phenotypes. It is expected that any genetic resources generated will be made broadly

available to the scientific community to enable investigation of the relevant neurobiological

mechanisms involved and provide critical foundational knowledge for the development of future

prevention, diagnostic, and therapeutic strategies.

Application budgets may not exceed $125,000 per year in direct costs for the R21 phase.

Applications may not exceed $250,000 per year in direct costs for the R33 phase.

The R21 phase may not exceed two years, while the R33 phase may not exceed 3 years. The total

project period may not exceed 5 years.

Letter of Intent Due Date(s)

30 days prior to the application due

date

Application Due Date(s)

June 24, 2019, December 18,

2019, June 24, 2020, December 18,

2020, June 24, 2021, December 17,

2021

National Institutes of Health

(NIH)

R01 Research Project

Grant

The purpose of this funding opportunity announcement (FOA) is to continue advancing our

understanding of the risks, development, progression, diagnosis, and treatment of malignancies

observed in individuals with an underlying HIV infection or Acquired Immune Deficiency

Syndrome (AIDS). These PQs are not intended to represent the full range of NCI's priorities in

HIV/AIDS-related cancer research. Rather, they are meant to challenge researchers to think about

and elucidate specific problems and paradoxes in key areas of AIDS-related cancer research that

are deemed important but have not received sufficient attention.

Provocative Questions in Cancer with an Underlying HIV Infection involves a set of 6 PQs. Each

research project proposed in response to this FOA must be focused on addressing one particular

research problem defined by one specific PQ selected from the list. Projects proposed to address

specific PQs may use strategies that incorporate ideas and approaches from multiple disciplines,

as appropriate. Transdisciplinary projects are encouraged as long as they serve the scientific focus

of the specific PQ chosen.

Application budgets are not limited but need to reflect the actual needs of the proposed R01

project. The total project period may not exceed 5 years.

Letter of Intent Due Date(s)

30 days prior to the application due

date

Application Due Date(s)

August 1, 2019; August 3, 2020

National Institutes of Health

(NIH)

R01 Research Project

Grant

This Funding Opportunity Announcement (FOA) invites applications investigating the cellular and

molecular mechanisms by which alcohol increases cancer risk.

Alcohol consumption is classified as carcinogenic to humans by the International Agency for

Research on Cancer (IARC; 2010, 2012) and the National Toxicology Program (NTP; 2014) of the

US Department of Health and Human Services. Target sites for alcohol-related carcinogenesis

include the upper aerodigestive tract, breast, liver, and colon. A better understanding of the

molecular basis by which alcohol increases cancer risk for certain tissues and organs could lead to

improved therapeutic approaches and preventative strategies and would provide guidance on

safe levels of alcohol consumption. Application budgets are not limited but need to reflect the

actual needs of the proposed project.

February 5

June 5

October 5 until September 8, 2020

National Institutes of Health

(NIH)

R01 Research Project

Grant

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and translational

research that will identify the specific biological or biobehavioral pathways through which physical

activity and/or weight control (either weight loss or avoidance of weight gain) may affect cancer

prognosis and survival. Research applications should test the effects of physical activity, alone or

in combination with weight control (either weight loss or avoidance of weight gain), on

biomarkers of cancer prognosis among cancer survivors identified by previous animal or

observational research on established biomarkers other than insulin/glucose metabolism,

especially those obtained from tumor tissue sourced from repeat biopsies where available.

Because many cancer survivor populations will not experience recurrence but will die of comorbid

diseases or may experience early effects of aging, inclusion of biomarkers of comorbid diseases

(e.g., cardiovascular disease) and of the aging process are also sought. Applications should use

experimental designs (e.g., randomized controlled clinical trials (RCTs), fractional factorial

designs), and will include transdisciplinary approaches that bring together behavioral intervention

expertise, cancer biology, and other basic and clinical science disciplines relevant to the pathways

being studied. Application budgets are not limited but need to reflect the actual needs of the

proposed project.

February 5

June 5

October 5 until September 8, 2021

National Institutes of Health

(NIH)

R01 Research Project

Grant

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate efforts to translate

scientific discoveries and engineering developments into methods or tools that address problems

in basic research to understand disease, or in applied research to assess risk, detect, prevent,

diagnose, treat, and/or manage disease. The rationale is to deliver new capabilities to meet

evolving requirements for technologies and methods relevant to the advance of research and

delivery of care in pre-clinical, clinical and non-clinical settings, domestic or foreign, for conditions

and diseases within the missions of participating institutes.

This FOA specifies a partnership structure that is expected to help bridge gaps in knowledge and

experience by engaging the strengths of academic, industrial, and other investigators. The

partners on each application should establish an inter-disciplinary, multi-institutional research

team to work in strategic alliance to implement a coherent strategy to develop and translate a

solution to their chosen problem. They are expected to plan, design, and validate that the

solution will be suitable for end users. Each partnership should include at least one academic and

one industrial organization. Each partnership should plan to transition a technology, method,

assay, device, and/or system from a demonstration of possibility to a status useful in the chosen

setting.

This FOA will support clinical trials that test functionality, or validate performance in the chosen

setting. Application budgets are not limited but need to reflect the actual needs of the proposed

project.

February 5

June 5

October 5 until January 8, 2021

National Institutes of Health

(NIH)

R01 Research Project

Grant

This Funding Opportunity Announcement (FOA) invites applications for implementation of

investigator-initiated multi-site interventional clinical trials (all phases). The trials should be

hypothesis-driven, milestone-defined, and related to NIA's research mission. Information about

NIA's mission can be found on the NIA website.

February 5

June 5

October 5 of every year until

September 08, 2022

National Institutes of Health

(NIH)

R01 Research Project

Grant

The purpose of this Funding Opportunity Announcement (FOA) is to support collaborative

research projects designed to address adverse sequelae of cancer therapies that persist and

become chronic comorbidities or develop as delayed posttreatment effects. This FOA supports

basic, translational, and/or clinical research projects that seek to identify the mechanisms of

therapy-induced adverse sequelae, clinically characterize the adverse sequelae, or translate the

mechanistic understanding into therapeutic approaches to prevent or minimize the development

of long-term sequelae. Research projects should focus on 1) mechanistic studies with

translational endpoints; and/or 2) longitudinal clinical phenotyping to identify and validate clinical

endpoints (biomarkers, imaging, patient-reported outcomes, or combined elements) for future

use in clinical trials that will evaluate the efficacy of interventions designed to prevent or reduce

specific adverse sequelae.

Application budgets are not limited but need to reflect the actual needs of the proposed project.

Letter of Intent Due Date(s)

30 days prior to the application due

date

Application Due Date(s)

September 30, 2019; February 11,

2020; September 30, 2020;

February 11, 2021; September 20,

2021; February 11, 2022

National Institutes of Health

(NIH)

R01 Research Project

Grant

The purpose of this Funding Opportunity Announcement (FOA) is to invite applications proposing

innovative analysis of existing social science, behavioral, administrative, and neuroimaging data to

study the etiology and epidemiology of substance using behaviors (defined as alcohol, tobacco,

prescription and other substances) and related disorders, prevention of substance use and HIV,

and health service utilization. This FOA encourages the analyses of public use and other extant

community-based or clinical datasets to their full potential in order to increase our knowledge of

etiology, trajectories of substance using behaviors and their consequences including morbidity

and mortality, risk and resilience in the development of psychopathology, strategies to guide the

development, testing, implementation, and delivery of high quality, effective and efficient

services for the prevention and treatment of substance use disorder and HIV.

Budgets may request no more than $499,999 direct costs per year and must reflect the actual

needs of the proposed project. The maximum period is 5 years.

every February 5, June 5,

October 5 until September 8, 2021

National Institutes of

Health (NIH)

Physical Activity and

Weight Control

Interventions Among

Cancer Survivors: Effects

on Biomarkers of

Prognosis and Survival

(R21 Clinical Trial

Optional)

This Funding Opportunity Announcement (FOA) encourages transdisciplinary and

translational research that will identify the specific biological or biobehavioral pathways

through which physical activity and/or weight control (either weight loss or avoidance

of weight gain) may affect cancer prognosis and survival. Research applications should

test the effects of physical activity, alone or in combination with weight control (either

weight loss or avoidance of weight gain), on biomarkers of cancer prognosis among

cancer survivors identified by previous animal or observational research on established

biomarkers other than insulin/glucose metabolism, especially those obtained from

tumor tissue sourced from repeat biopsies where available. Because many cancer

survivor populations will not experience recurrence but will die of comorbid diseases or

may experience early effects of aging, inclusion of biomarkers of comorbid diseases

(e.g., cardiovascular disease) and of the aging process are also sought. Applications

should use experimental designs (e.g., randomized controlled clinical trials (RCTs),

fractional factorial designs), and will include transdisciplinary approaches that bring

together behavioral intervention expertise, cancer biology, and other basic and clinical

science disciplines relevant to the pathways being studied. 

8-Sep-21

National Institutes of

Health (NIH)

Using Small Molecules

and Molecular Genetics

to Identify Novel Targets

and Mechanisms

Contributing to Tumor

Immune Evasion (R01)

The purpose of this funding opportunity (FOA) is to stimulate research on the

identification of new and novel targets and mechanisms involved in tumor immune

evasion, which may be amenable to analysis by small molecules, pharmacological, or

molecular genetics approaches. A specific focus of this FOA is to encourage cross

disciplinary collaborations between immunologists, cell biologists, medicinal chemists,

pharmacologists, and molecular biologists

8-Sep-20

National Institutes of Health

(NIH)

High Priority HIV/AIDS

Research within the

Mission of the NIDDK

(R01 Clinical Trial

Optional

This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the

mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that

addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research

(OAR). 

January ,8, 2021

National Institutes of Health

(NIH)

Investigations on

Primary

Immunodeficiency

Diseases/Inborn Errors

of Immunity (R01

Clinical Trial Not

Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to advance the discovery and

characterization of primary immunodeficiency diseases, also referred to as inborn errors of

immunity, to understand the causes and mechanisms of disease, to enable early detection and

molecular diagnosis, and to support the development of strategies to treat and eventually cure

these disorders

May ,8, 2021

National Institutes of Health

(NIH)

Promoting NICHD Areas

of Research for

HIV/AIDS in Maternal

and Child Health (R01)

The purpose of this Funding Opportunity Announcement (FOA) is to stimulate HIV/AIDS research

by addressing scientific areas of primary interest to NICHD, Maternal and Pediatric Infectious

Disease Branch (MPIDB) and the Office of AIDS Research (OAR).

September ,8, 2020 

National Institutes of Health

(NIH)

Functional Genetics,

Epigenetics, and Non-

coding RNAs in

Substance Use Disorders

(R01)

Genetic and genomic studies have identified genes and gene variants that may impact the

fundamental biological mechanisms underpinning substance use disorders (SUDs).  Discovery of

these genes/variants, while extremely valuable, is only the first step in understanding the

molecular processes that influence SUDs. This Funding Opportunity Announcement (FOA)

encourages basic functional genetic and genomic research in two areas:  1. functional validation

to determine which candidate genes/variants/epigenetic/non-coding RNA features have an

authentic role in SUDs, and 2. detailed elucidation of the molecular pathways and processes

modulated by candidate genes/variants, particularly for those genes with an unanticipated role in

SUDs

May ,8, 2020

National Institutes of Health

(NIH)

Molecular and Genetic

Characterization of

Inborn Errors of

Immunity (R01 Clinical

Trial Not Allowed)

The purpose of this Funding Opportunity Announcement (FOA) is to advance the experimental

validation and functional characterization of genetic variants in coding or non-coding genomic

regions that result in inborn errors of immunity/primary immunodeficiency diseases and to

elucidate the molecular, cellular, and immunological mechanisms of these disorders.

Understanding the genetic basis of primary immunodeficiency disorders is essential for their

diagnosis, prognosis, and the development of precision therapeutics.         

January ,8, 2022

National Institutes of Health

(NIH)

Processing and

Presentation of Non-

Conventional MHC

Ligands (R01 Clinical

Trial Not Allowed)

This Funding Opportunity Announcement (FOA) invites applications to characterize antigen

processing and presentation mechanisms used in the generation of novel peptidic and non-

peptidic ligands presented by classical and non-classical MHC class I and class II molecules, and to

determine the contribution of these unique antigenic ligands to: protective immune responses to

infectious pathogens and/or vaccines; pathogen-associated immune pathogenesis; and/or in the

induction/progression or prevention of immune-mediated diseases. These studies may facilitate

the development of novel tools and reagents to advance design of immune-based therapeutics

and vaccines.      

January ,8, 2022

National Institutes of

Health (NIH)

NIH Research Project

Grant (Parent R01

Clinical Trial Not

Allowed)

The NIH Research Project Grant supports a discrete, specified, circumscribed project in

areas representing the specific interests and competencies of the investigator(s). The

proposed project must be related to the programmatic interests of one or more of the

participating NIH Institutes and Centers (ICs) based on their scientific missions.  

This Funding Opportunity Announcement does not accept applications proposing

clinical trial(s)

January ,8, 2022

National Institutes of

Health (NIH)

NIH

Exploratory/Develop

mental Research

Grant Program

(Parent R21 Clinical

Trial Not Allowed)

The NIH Exploratory/Developmental Grant supports exploratory and developmental

research projects by providing support for the early and conceptual stages of these

projects. These studies may involve considerable risk but may lead to a breakthrough in

a particular area, or to the development of novel techniques, agents, methodologies,

models, or applications that could have a major impact on a field of biomedical,

behavioral, or clinical research. 

January ,8, 2022

National Institutes of

Health (NIH) Human Subjects

Mechanistic and

Minimal Risk Studies

(R01 Clinical Trial

Optional)

The purpose of this FOA is to encourage applications that seek to conduct studies of

the visual system.  This FOA will support applications that either

Those that involve human subjects, but are not NIH-defined clinical trials (see NOT-OD-

15-015); or

Those that are NIH-defined clinical trials and are designed to address either: 1)

mechanisms underlying human vision in health and disease; or 2) interventions that

entail procedures with minimal risk to subjects. 

A mechanistic trial is defined as "A study designed to understand a biological or

behavioral process, the pathophysiology of a disease, or the mechanism of action of an

intervention.  "Minimal risk" means that the probability and magnitude of harm or

discomfort anticipated in the research are not greater in and of themselves than those

ordinarily encountered in daily life or during the performance of routine physical or

psychological examinations or tests.

NIH-defined clinical trial applications that are neither mechanistic nor minimal risk are

not eligible for this FOA.  Large-scale clinical trials, human gene-transfer and stem cell

therapy trials, and other complex or high resource- or safety-risk clinical trials are not

appropriate for this FOA.  Applicants are strongly advised to consult with NEI program

staff prior to submitting an application with human subjects to determine the

appropriate funding opportunity

January ,8, 2021

National Institutes of

Health (NIH)

Innovative Therapies

and Tools for

Screenable Disorders

in Newborns (R01 -

Clinical Trial Optional)

This FOA encourages research relevant to the development of therapeutic

interventions for potentially fatal or disabling conditions that have been identified

through newborn screening, as well as "high priority" genetic conditions where

screening may be possible in the near future.

Demonstrating the benefits of treatment is often a primary criterion for including a

condition on a newborn screening panel; therefore, for this FOA, a "high priority"

condition is one where screening is not currently recommended but would significantly

benefit from early identification and treatment

May ,8, 2021

National Institutes of

Health (NIH)

NEI Vision Research

Epidemiology Grant

(UG1 Clinical Trial Not

Allowed)

The National Eye Institute invites applications for its vision research epidemiology grant

(UG1 clinical trial not allowed) funding opportunity. This supports epidemiologic studies

that use creative and innovative approaches to studying vision diseases and disorders

with high public impact, to inform prevention and treatment strategies as well as basic

sciences research.

US and foreign for-profit and non-profit organisations and public and private

organisations may apply.

Application budgets are not limited but need to reflect the actual needs of the

proposed project. The maximum period is five years. The number of awards is

contingent upon NIH appropriations and the submission of a sufficient number of

meritorious applications.

September ,08, 2021

National Institutes of

Health (NIH)

Novel Nucleic Acid

Sequencing Technology

Development (R21

Clinical Trial Not

Allowed)

This Funding Opportunity Announcement (FOA) solicits R21 grant applications to

develop novel technologies that will enable substantive (no less than an order of

magnitude) improvement in DNA sequencing, and practical methods for direct RNA

sequencing. Applicants may propose to develop novel complete sequencing systems,

investigate challenges underlying key novel system components, or propose

improvements of at least an order of magnitude improvement to existing systems. 

Exploration of methods other than those currently in use is highly encouraged.  High-

risk/high-payoff applications are appropriate to achieve the goals of this FOA.

June 26, 2020, by 5:00 PM

National Institutes of

Health (NIH)

Exploiting Genome or

Epigenome Editing to

Functionally Validate

Genes or Variants

Involved in Substance

Use Disorders (R21/R33

Clinical Trial Not

Allowed)

The purpose of this initiative is to support projects which exploit genome or epigenome

editing to functionally validate and characterize genes or variants involved in substance

use disorder-relevant phenotypes.  It is expected that any genetic resources generated

will be made broadly available to the scientific community to enable investigation of

the relevant neurobiological mechanisms involved and provide critical foundational

knowledge for the development of future prevention, diagnostic, and therapeutic

strategies

18-Dec-21

National Institutes of

Health (NIH)

Explainable Artificial

Intelligence for

Decoding and

Modulating Neural

Circuit Activity Linked to

Behavior (R01 Clinical

Trial Optional)

Explainable Artificial Intelligence (XAI) aims to provide strong predictive value along

with mechanistic understanding of AI by combining machine learning techniques with

effective explanatory techniques. This Funding Opportunity Announcement (FOA)

solicits applications in the area of XAI applied to neuroscientific questions of encoding,

decoding, and modulation of neural circuits linked to behavior. This FOA encourages

collaborations between computationally and experimentally-focused investigators. This

FOA seeks the development of machine learning algorithms that are able to

mechanistically explain how experimental manipulations affect cognitive, affective, or

social processing in humans or animals. Proof-of-concept applications aimed at

improving the current state of the technology that uses XAI to provide unbiased,

hierarchical explanations of causal relationships between complex neural and

behavioral data are also appropriate .

March ,11, 2022

National Organization for

Rare Disorders

National Organization

for Rare Disorders The NORD Research Grant Program provides seed-money grants to qualified

investigators for scientific and/or clinical research. The hope is that these studies

ultimately will lead to new diagnostics, treatments, and/or cures for rare diseases.

NORD’s program provides grants for the study of diseases for which there are few other

sources of funding. Grants are made possible through the generosity of allies in the rare

disease community and supporters who have donated into NORD’s research fund.

We have no information from

the funder yet about the next

call. Based on past experience,

we forecast the deadline to be

around June 2020. This call is

repeated once a year.

National Science

Foundation, US

Combustion and fire

systems programmeThe National Science Foundation, under its Division of Chemical, Bioengineering,

Environmental and Transport Systems’ chemical process systems cluster, invites

applications for its combustion and fire systems programme. This supports

fundamental research and education on combustion and fire systems. Among the

broader societal impacts of the programme are cleaner global and local environments,

enhanced public safety, improved energy and homeland security, useful new materials

and more efficient manufacturing. The programme provides basic knowledge that can

be used by others in development of systems for combustion and plasma applications

and for mitigating the effects of fire.

No deadline

National Science

Foundation, US

Catalysis The Catalysis program is part of the Chemical Process Systems cluster, which also

includes: 1) the Electrochemical Systems program; 2) the Interfacial Engineering

program; and 3) the Process Systems, Reaction Engineering, and Molecular

Thermodynamics program.

The goals of the Catalysis program are to increase fundamental understanding in

catalytic engineering science and to advance the development of catalytic materials

and reactions that are beneficial to society.  Research in this program should focus on

new concepts for catalytic materials and reactions, utilizing synthetic, theoretical, and

experimental approaches.  Target applications include fuels, specialty and bulk

chemicals, environmental catalysis, biomass conversion to fuels and chemicals,

conversion of greenhouse gases, and generation of solar hydrogen, as well as efficient

routes to energy utilization.

No deadline

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 1 Water

Management 2020Implementing sustainable, integrated management of water resources in the

Mediterranean, under climate change conditions.

TYPE OF ACTION:IA Innovation Action

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 7.5 million

Stage 1 Pre-proposals – 06

May, 2020 (17:00h Barcelona

Time)

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 1 Agro-Food

Value chain 2020THEMATIC AREA:Agro-Food value chain

TOPIC:

1.3.1-2020 (IA) Valorising the health benefits of the Traditional Mediterranean food

products

TYPE OF ACTION:IA Innovation Action

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 8.8 million

Stage 1 Pre-proposals – 06

May, 2020 (17:00h Barcelona

Time)

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 1 Farming

Systems 2020 RIATHEMATIC AREA:Farming System RIA

TOPIC:

1.2.1-2020 Genetic conservation and animal feeds

Sub-topic A) Conservation and valorization of local Animal Genetic Resources (RIA)

TYPE OF ACTION:RIA Research and Innovation action

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 3,5 million

Stage 1 Pre-proposals – 06

May, 2020 (17:00h Barcelona

Time)

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 1 Farming

Systems 2020 IATHEMATIC AREA:Farming systems IA

TOPIC:

Topic 1.2.1-2020 Genetic conservation and animal feeds

Sub-topic B) Alternative animal feeds (IA)

TYPE OF ACTION:IA Innovation Action

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 7,2 million

Stage 1 Pre-proposals – 06

May, 2020 (17:00h Barcelona

Time)

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 1 Nexus 2020 THEMATIC AREA:Nexus

TOPIC:

Topic 1.4.1 (IA) Demonstrating benefits of the Water-Ecosystem-Food Nexus approach

in delivering optimal economic development, achieving high level of environmental

protection and ensuring fair access to natural resources.

TYPE OF ACTION:IA Innovation Action

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 6 million

Stage 1 Pre-proposals – 06

May, 2020 (17:00h Barcelona

Time)

PRIMA Section 2 Calls:

National Funding –

Lebanon (RIA

Actions)

Thematic area: Water Management

Topic 2.1.1 (RIA) Low cost, lean solutions for enhancing irrigation efficiency of small-scale

farms.

Thematic area: Farming Systems

Topic 2.2.1 (RIA) Re-design the agro-livelihood systems to ensure resilience.

Thematic area: Agro-food Chain

Topic 2.3.1 (RIA) New optimization models of the agro food supply chain system to fair price for

consumers and reasonable profit share for farmers.

Call Deadlines:

Stage 1 Pre-proposals – 15 April,

2020 (17:00h Barcelona time)

Stage 2 Full proposals – 16

September, 2020 (17:00h

Barcelona time)

PRIMA – Partnership for

Research and Innovation

in the Mediterranean

Area

Section 2 Multitopic

2020THEMATIC AREA:Multi-Topic

TOPIC:

Transnational call funded by Participating States

TYPE OF ACTION:RIA Research and Innovation activities

TOTAL INDICATIVE AMOUNT ALLOCATED TO THIS CALL:EUR 38 million

Stage 1 Pre-proposals – 13

May, 2020 (17:00h Barcelona

time)

Retina UK, GB Research grants Retina UK invites applications for funding for high quality research projects looking at

the causes and potential treatments for all forms of inherited retinal disease. Potential

applicants should note that only projects that are clearly focused on our charitable

objectives will be considered. The charity mainly – but not exclusively – funds research

work in the UK. Applications from other countries will be considered but are only likely

to be financed if a project is deemed “exceptional” by our MAB and demonstrates

meaningful collaboration with UK scientists and institutions.

01, September, 2020

Sarcoma Foundation of

America

Sarcoma Foundation of

America Research

Grants – 2020 Funding

Opportunity

Announcement

The Sarcoma Foundation of America (SFA) is pleased to announce a research funding opportunity

to provide one-year grants in the amount of $50,000, to support translational science research on

the etiology, molecular biology, pathogenesis, diagnosis, and treatment of human sarcomas. In

support of our overall mission to fund research and increase awareness and advocacy for

sarcoma patients and their families, the goal of the SFA grant program is to encourage research

that results in improved therapeutic options for sarcoma patients. The SFA will only accept

applications that focus on the following areas of research for the 2020 cycle:

• Immunotherapy

• Omic characterization of sarcomas and definition of novel targets

• Omic patterns of sensitivity and resistance to existing agents

• Systemic therapy combinations

• Gene Therapy

January,31,2020

5:00 pm ET

The American Academy

of Optometry

Allergan Foundation

Research Grant

The American Academy of Optometry invites proposals for its Allergan Foundation

research grant. This supports research in the area of glaucoma or the anterior segment.

The award is open to all faculty and researchers in optometry and vision science with

preference given to North American applicants. The PI must be a member of the AAO.

The award includes a one-year research grant worth USD 60,000 and a travel grant of

USD 750 for the principal investigator and up to three co-investigators to attend the

annual meeting of the AAO.

July 15, 2020.

The Glaucoma

Foundation

Glaucoma Foundation The Glaucoma Foundation offers grants to researchers striving to improve the lives of

glaucoma patients through novel innovations and scientific advances. The area of

current focus for TGF’s Grant Research program is exfoliation syndrome and exfoliation

glaucoma.Initial grant funding for a one-year period is for up to $60,000; a grantee is

permitted to apply for a grant renewal of up to $60,000. A renewal grant is a one year

grant based upon research findings from the initial research.

September ,11, 2020

The Marfan Foundation Clinical Research

ProgramThe Marfan Foundation is requesting proposals for clinical research studies focusing

outside of the cardiovascular arena. Proposals can be retrospective or prospective and

may utilize data obtained through registries/databases, observational studies, and

surveys. Proposals should conduct scientifically rigorous research that produces valid

new knowledge with clinical and quality of life endpoints in the absence of randomized

clinical trials. Proposals may focus on patient-oriented research, including

epidemiologic, behavioral, quality of life studies and outcomes research. Special areas

of interest include ophthalmology, orthopedics, pulmonology, gastroenterology, allergy

and immunology, autism, ADHD, ADD, physical therapy/exercise, pain and fatigue,

mental and emotional health, behavioral studies and/or nutrition studies.

Grants can range from $25,000–$50,000 per year for one or two years.

June ,2, 2020

The Marfan Foundation Faculty Grant Program The faculty grant program supports two-year grants for basic or clinical research for all disciplines

in Marfan syndrome, Ehlers Danlos syndrome, Loeys Dietz syndrome and other related

conditions. We are pleased to announce that one faculty grant will be funded by the Loeys-Dietz

Syndrome Foundation for studies related to Loeys-Dietz syndrome vasculature or TGFβ.

June ,1, 2020

The Marfan Foundation Clinical Research

ProgramThe Marfan Foundation is requesting proposals for clinical research studies focusing

outside of the cardiovascular arena. Proposals can be retrospective or prospective and

may utilize data obtained through registries/databases, observational studies, and

surveys. Proposals should conduct scientifically rigorous research that produces valid

new knowledge with clinical and quality of life endpoints in the absence of randomized

clinical trials. Proposals may focus on patient-oriented research, including

epidemiologic, behavioral, quality of life studies and outcomes research. Special areas

of interest include ophthalmology, orthopedics, pulmonology, gastroenterology, allergy

and immunology, autism, ADHD, ADD, physical therapy/exercise, pain and fatigue,

mental and emotional health, behavioral studies and/or nutrition studies.

Grants can range from $25,000–$50,000 per year for one or two years.

June ,2, 2020

U.S. Embassy’s Public Affairs

Section in Lebanon

U.S. Embassy Lebanon

PAS Small Grants Annual

Program Statement

This funding opportunity supports enhancing the role of women in society through programs

focused on civic participation (such as social entrepreneurship, volunteerism, and community

engagement); economic empowerment; and increased access to education; and on fostering

youth empowerment through various programs [examples of which include but are not limited

to: science, technology, engineering, architecture, and math (STEAM); entrepreneurship; and

inclusive citizenship]

As only one application/institution is allowed to each call (/quarter for the first opportunity),

please send OGC (Ms. Haydar and Ms Mhanna) a brief description of your proposal by the

deadlines highlighted in yellow above, for the Provost to review and decide on the proposal to be

submitted on behalf of the university for each call.

($50,000 award ceiling. Deadlines: Dec 31, 2019; March 31, 2020; June 30, 2020 and Aug 30,

2020)

deadlines for brief description of

proposal submission to OGC are:

Dec 15, 2019; January 30, 2020;

April 30, 2020 and June 30, 2020

respectively

UK Research and

Innovation (UKRI)

GCRF 'Conflict

Intersections' Global

Partnership

Development Awards:

Prevention and

Resilience at the

Intersections between

Conflict, Fragility and

Wider Development

Challenges and Risks

The Arts and Humanities Research Council (AHRC), on behalf of UKRI, is pleased to

announce a new funding initiative for Partnership Development awards under the

Global Challenges Research Fund’s Collective Programme. This call will support the

development of equitable partnerships and an interdisciplinary community to explore

the intersections between conflict and fragility (SDG 16: Peace, Justice and Strong

Institutions & GCRF Conflict portfolio) and wider development challenges (and other

SDGs and GCRF portfolios) such as health, environmental resilience, sustainable cities

and food systems, as well as cross-cutting development issues such as gender,

inequalities, poverty reduction and sustainable livelihoods.

Applicants may apply for funding of up to £200,000 (fEC) over a period of between 12

and 24 months in duration. Applications are welcome from researchers based in the

UK or from organisations based in Low and Middle Income countries (LMIC) on the DAC

list of ODA recipients. All applications must include partnership and collaboration

between UK and LMIC participants.

Closing Date: 06/03/2020

US Department of Energy Solar Energy

Technologies Office

funding opportunity –

topic area 8 small

innovative projects in

solar

This supports research and development projects with a focus on innovative and novel ideas in

photovoltaics and concentrating solar-thermal power that are riskier than research ideas based

on established technologies. Awards are worth up to USD 300,000 each for a period of one year.

9-Apr-20

USDA Department of

Agriculture

Scientific Exchanges

Initiative

Department of

Agriculture

Foreign Agricultural

Service

The Scientific Exchanges Initiative advances USDA’s agricultural research goals to

promote collaborative programs among agricultural professionals of eligible countries,

the United States, the international agricultural research system, and United States

entities conducting research in the agricultural sciences by providing fellowships to

individuals from eligible countries who specialize or have experience in agricultural

education, research, extension, or other related

fields. Fellowships promote food security and economic growth in eligible countries by

educating a new generation of agricultural scientists, increasing scientific knowledge

and collaborative research to improve agricultural productivity, and extending that

knowledge to users and intermediaries in the marketplace. The collaborative nature of

the training and research programs benefits the fellow, his or her home institution, and

partner country; the U.S. host institution, its professors, researchers, and students; and

the global agricultural sector by improving agricultural productivity, systems, and

processes in partnering nations through the transfer of new science and agricultural

technologies.

May 29, 2020  

Volkswagen Foundation |

VolkswagenStiftung, DE

Artificial intelligence and

the society of the future

– planning grants

The initiative focuses on joint, integrative research approaches in the social sciences

and the engineering sciences. Against the background of the current and emerging

developments in the field of "Artificial Intelligence" the Foundation wishes to support

projects dealing with the development of new perspectives and insights with a view to

shaping the future of society as well as technology. The aim is to enable novel project

constellations and interdisciplinary cooperations in a scientific and socially highly topical

area through a shift in thinking towards new perspectives and solutions.

An essential challenge and at the same time a special opportunity for the participating

disciplines lies in the joint development of a specific topic and the associated research

issues as well as in the necessary expansion of the respective range of methods. 

July,7, 2020

2pm CET

Water Research

Foundation, US

Emerging opportunities

proposalThe Water Research Foundation invites applications for its emerging opportunities

proposal. This supports emerging and time critical issues, and partnering opportunities

and add-ons to current projects.

Projects may last between three months and one year, and are worth between USD

25,000 and USD 200,000. Project add-ons are limited to USD 25,000.

No deadline

Wellcome Trust Research Development

Awards in Humanities,

Social Science and

Bioethics

These awards are for groups of researchers who want the time and resources to shape the

direction of their future work. The development programmes will lay the foundation for research

that takes risks and pushes academic boundaries. You can apply for a Research Development

Award if you're part of an emerging or established research group working in health-related

humanities, social sciences or bioethics.

Level of funding: Up to £1 million

Duration of funding: 3 to 5 years

Preliminary applications deadline

3 March 2020

Site visits

September/October 2020

Full applications deadline

January 2021

Wellcome Trust Collaborative Awards in

Science

Collaborative Awards promote the development of new ideas and speed the pace of discovery.

We fund teams of researchers, consisting of independent research groups, to work together on

the most important scientific problems that can only be solved through collaborative efforts.

Level of funding:

Up to £4 million

Preliminary application deadline

21 April 2020,

Full application deadline

16 July 2020,